van Oort I - Search Results

1

Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer.

Simnica D, Smits M, Willscher E, Fanchi LF, Kloots ISH, van Oort I, Gerritsen W, Mehra N, Binder M. Simnica D, et al. Among authors: van oort i. JCO Precis Oncol. 2020 Nov;4:1374-1385. doi: 10.1200/PO.20.00209. JCO Precis Oncol. 2020. PMID: 35050788

2

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the Netherlands.

Wissing MD, van Oort IM, Gerritsen WR, van den Eertwegh AJ, Coenen JL, Bergman AM, Gelderblom H. Wissing MD, et al. Clin Genitourin Cancer. 2013 Sep;11(3):238-250.e1. doi: 10.1016/j.clgc.2013.04.004. Epub 2013 May 6. Clin Genitourin Cancer. 2013. PMID: 23659772

3

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide.

Benoist GE, Hendriks RJ, Mulders PF, Gerritsen WR, Somford DM, Schalken JA, van Oort IM, Burger DM, van Erp NP. Benoist GE, et al. Clin Pharmacokinet. 2016 Nov;55(11):1369-1380. doi: 10.1007/s40262-016-0403-6. Clin Pharmacokinet. 2016. PMID: 27106175 Free PMC article. Review.

4

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

Badrising SK, van der Noort V, Hamberg P, Coenen JL, Aarts MJ, van Oort IM, van den Eertwegh AJ, Los M, van den Berg HP, Gelderblom H, Vrijaldenhoven S, Kerver ED, van Voorthuizen T, de Jong IJ, Haanen JB, Bergman AM; Dutch Uro-Oncology Study Group (DUOS). Badrising SK, et al. Oncology. 2016;91(5):267-273. doi: 10.1159/000448219. Epub 2016 Aug 20. Oncology. 2016. PMID: 27544669

5

Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

Benoist GE, van Oort IM, Smeenk S, Javad A, Somford DM, Burger DM, Mehra N, van Erp NP. Benoist GE, et al. Br J Clin Pharmacol. 2018 Jan;84(1):122-129. doi: 10.1111/bcp.13425. Epub 2017 Oct 18. Br J Clin Pharmacol. 2018. PMID: 28881501 Free PMC article.

6

223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice.

van der Doelen MJ, Kuppen MCP, Jonker MA, Mehra N, Janssen MJR, van Oort IM, Gerritsen WR. van der Doelen MJ, et al. Clin Nucl Med. 2018 Jan;43(1):9-16. doi: 10.1097/RLU.0000000000001904. Clin Nucl Med. 2018. PMID: 29166331

7

Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer.

Westdorp H, Kuip EJM, van Oort IM, Kramers C, Gerritsen WR, Vissers KCP. Westdorp H, et al. J Pain Symptom Manage. 2018 Apr;55(4):e6-e8. doi: 10.1016/j.jpainsymman.2017.11.016. Epub 2017 Nov 22. J Pain Symptom Manage. 2018. PMID: 29175468 Free article. No abstract available.

8

The Combination of Enzalutamide and Opioids: A Painful Pitfall?

Benoist GE, van Oort IM, Burger DM, Koch BCP, Mehra N, van Erp NP. Benoist GE, et al. Eur Urol. 2019 Feb;75(2):351-352. doi: 10.1016/j.eururo.2018.09.011. Epub 2018 Sep 21. Eur Urol. 2019. PMID: 30245086 No abstract available.

9

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives.

van der Doelen MJ, Mehra N, Hermsen R, Janssen MJR, Gerritsen WR, van Oort IM. van der Doelen MJ, et al. Clin Genitourin Cancer. 2019 Apr;17(2):79-87. doi: 10.1016/j.clgc.2018.11.008. Epub 2018 Nov 22. Clin Genitourin Cancer. 2019. PMID: 30558834 Review.

10

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands.

Westgeest HM, Kuppen MCP, van den Eertwegh AJM, de Wit R, Coenen JLLM, van den Berg HPP, Mehra N, van Oort IM, Fossion LMCL, Hendriks MP, Bloemendal HJ, van de Luijtgaarden ACM, Ten Bokkel Huinink D, van den Bergh ACMF, van den Bosch J, Polee MB, Weijl N, Bergman AM, Uyl-de Groot CA, Gerritsen WR. Westgeest HM, et al. Clin Genitourin Cancer. 2019 Oct;17(5):e946-e956. doi: 10.1016/j.clgc.2019.05.018. Epub 2019 May 31. Clin Genitourin Cancer. 2019. PMID: 31439536 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page